Movement Alert｜SPYRE THERAPEUTICS INC Rises 6.21% in Regular Trading, Trading at $89.915

Market Focus

Yesterday

On September 30, SPYRE THERAPEUTICS INC rose 6.21% in regular trading, trading at $89.915/share, with turnover of $46.10 million.

Within the Biotechnology sector where SPYRE THERAPEUTICS INC belongs, individual stocks showed mixed performance. Among notable movers, Connect Biopharma Holdings Ltd. up 24.42%, Valion Bio Inc up 22.26%, Capricor Therapeutics up 13.19%, Kodiak Sciences Inc. up 0.42%, Moderna, Inc. down 5.95%.

SPYRE THERAPEUTICS INC is a clinical-stage biotechnology company focused on developing next-generation therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4b7), SPY002 (anti-TL1A), SPY003 (anti-IL-23), and multiple combination therapy candidates. Earlier this month, the company reported that SPY003 met the primary endpoint in its Phase 2 Skyline trial for ulcerative colitis, achieving a 20% clinical-remission rate and a 30% endoscopic-improvement rate at week 12, completing clinical proof-of-concept for all three components of its IBD strategy.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1148383970"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148383970\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148383970?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-30 22:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148383970","market":"us","top_or_hot":-1,"title":"Movement Alert｜SPYRE THERAPEUTICS INC Rises 6.21% in Regular Trading, Trading at $89.915","media":"Market Focus","content":"<p><p>On September 30, SPYRE THERAPEUTICS INC rose 6.21% in regular trading, trading at $89.915/share, with turnover of $46.10 million.</p><p>Within the Biotechnology sector where SPYRE THERAPEUTICS INC belongs, individual stocks showed mixed performance. Among notable movers, Connect Biopharma Holdings Ltd. up 24.42%, Valion Bio Inc up 22.26%, Capricor Therapeutics up 13.19%, Kodiak Sciences Inc. up 0.42%, Moderna, Inc. down 5.95%.</p><p>SPYRE THERAPEUTICS INC is a clinical-stage biotechnology company focused on developing next-generation therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4b7), SPY002 (anti-TL1A), SPY003 (anti-IL-23), and multiple combination therapy candidates. Earlier this month, the company reported that SPY003 met the primary endpoint in its Phase 2 Skyline trial for ulcerative colitis, achieving a 20% clinical-remission rate and a 30% endoscopic-improvement rate at week 12, completing clinical proof-of-concept for all three components of its IBD strategy.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜SPYRE THERAPEUTICS INC Rises 6.21% in Regular Trading, Trading at $89.915</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜SPYRE THERAPEUTICS INC Rises 6.21% in Regular Trading, Trading at $89.915\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-30 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 30, SPYRE THERAPEUTICS INC rose 6.21% in regular trading, trading at $89.915/share, with turnover of $46.10 million.</p><p>Within the Biotechnology sector where SPYRE THERAPEUTICS INC belongs, individual stocks showed mixed performance. Among notable movers, Connect Biopharma Holdings Ltd. up 24.42%, Valion Bio Inc up 22.26%, Capricor Therapeutics up 13.19%, Kodiak Sciences Inc. up 0.42%, Moderna, Inc. down 5.95%.</p><p>SPYRE THERAPEUTICS INC is a clinical-stage biotechnology company focused on developing next-generation therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4b7), SPY002 (anti-TL1A), SPY003 (anti-IL-23), and multiple combination therapy candidates. Earlier this month, the company reported that SPY003 met the primary endpoint in its Phase 2 Skyline trial for ulcerative colitis, achieving a 20% clinical-remission rate and a 30% endoscopic-improvement rate at week 12, completing clinical proof-of-concept for all three components of its IBD strategy.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1148383970","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148383970","pubTimestamp":1790779690,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 30, SPYRE THERAPEUTICS INC rose 6.21% in regular trading, trading at $89.915/share, with turnover of $46.10 million.Within the Biotechnology sector where SPYRE THERAPEUTICS INC belongs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC"},"translate_title":"走势警报|SPYRE THERAPEUTICS INC 在常规交易中上涨 6.21%，交易价格为 89.915 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":1},"content_text":"On September 30, SPYRE THERAPEUTICS INC rose 6.21% in regular trading, trading at $89.915/share, with turnover of $46.10 million.Within the Biotechnology sector where SPYRE THERAPEUTICS INC belongs, individual stocks showed mixed performance. Among notable movers, Connect Biopharma Holdings Ltd. up 24.42%, Valion Bio Inc up 22.26%, Capricor Therapeutics up 13.19%, Kodiak Sciences Inc. up 0.42%, Moderna, Inc. down 5.95%.SPYRE THERAPEUTICS INC is a clinical-stage biotechnology company focused on developing next-generation therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4b7), SPY002 (anti-TL1A), SPY003 (anti-IL-23), and multiple combination therapy candidates. Earlier this month, the company reported that SPY003 met the primary endpoint in its Phase 2 Skyline trial for ulcerative colitis, achieving a 20% clinical-remission rate and a 30% endoscopic-improvement rate at week 12, completing clinical proof-of-concept for all three components of its IBD strategy.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}